Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Elan provides update post restructuring announcement of Tysabri collaboration
Procedural Variations in the Stroop and the Symbol Digit Modalities Test: Impact on Patients with Multiple Sclerosis.
Yield of training exchanges between Europe and Sub-Saharan Africa.
Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis.
Prediction of risk of fracture in the tibia due to altered bone mineral density distribution resulting from disuse: A finite element study.
JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants.
Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
Associations between Proprioceptive Neural Pathway Structural Connectivity and Balance in People with Multiple Sclerosis.
Plasma biomarkers discriminate clinical forms of multiple sclerosis.
Improved determination of the myelin water fraction in human brain using magnetic resonance imaging through Bayesian analysis of mcDESPOT.
Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Smoking and inflammation: evidence for a synergistic role in chronic disease.
Assessment of jugular endovascular malformations in chronic cerebrospinal venous insufficiency: colour-Doppler scanning and catheter venography compared with intravascular ultrasound.
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Combined use of pharmacophoric models together with drug metabolism and genotoxicity "in silico" studies in the hit finding process.
Advanced MRI in multiple sclerosis: current status and future challenges.
Mystery Case: Balo concentric sclerosis.
Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form.
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.
Assay selection affects John Cunningham virus serostatus classification in multiple sclerosis.
Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis.
Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients.
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis.
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
The high cost of spasticity in multiple sclerosis to individuals and society.
Pages
« first
‹ previous
…
284
285
286
287
288
289
290
291
292
…
next ›
last »